G Hirst - Ctr Canc, Univ Calif San Francisco

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 20 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Identification of biomarkers associated with therapeutic resistance: Quantitative protein/phosphoprotein analysis of 750 patients across 8 arms of the neoadjuvant I-SPY 2 TRIAL for high-risk early stage breast cancer

Julia Wulfkuhle,Denise Wolf,Christina Yau,Lamorna Brown-Swigart, Rosa I. Gallagher,Gillian Hirst,Laura Sit, Smita Asare, Nola Hylton, Angela DeMichele, Douglas Yee, Jo Chien, Hope Rugo, John Park, Kathy Albain, Rita Nanda, Debu Tripathy, Richard Schwab, Don Berry, Laura Esserman, Laura van t'Veer, Emanual Petricoin

CANCER RESEARCH（2021）

Cited0Views0Bibtex

Abstract P5-15-01: the Use of 18F-FDG PET/CT As an Initial Staging Procedure for Stage II-III Breast Cancer Reduces False Positives, Costs, and Time to Treatment: A Multicenter Value Analysis in the I-SPY2 Trial

CJ Hyland,F Varghese,C Yau,H Beckwith,K Khoury,W Varnado,G Hirst,J Chien,D Yee,C Isaacs,A Forero-Torres,L Esserman,M Melisko

Cancer researchno. 4_Supplement (2019): P5-01

Cited0Views0Bibtex

Abstract PD4-04: Role of Breast MRI in Predicting Pathologically Negative Nodes after Neoadjuvant Chemotherapy in Cn0 Patients in the I-SPY2 Trial

ME van der Noordaa,L Esserman,C Yau,R Mukhtar, E Price,N Hylton, H Abe,D Wolverton, EP Crane, KA Ward,M Nelson, BL Niell,K Oh,KR Brandt,DH Bang,H Ojeda-Fournier,M Eghtedari, PA Sheth,WK Bernreuter,H Umphrey, MA Rosen, B Dogan,W Yang,B Joe,L van 't Veer,G Hirst,R Lancaster,A Wallace, M Alvaredo,F Symmans,S Asare,JC Boughey

Cancer researchno. 4_Supplement (2019): PD4-04

Cited0Views0Bibtex

Role of breast MRI in predicting pathologically negative nodes after neoadjuvant chemotherapy in cN0 patients in the I-SPY2 trial

M. E. van der Noordaa,L. Esserman,C. Yau,R. Mukhtar,E. Price,N. Hylton,H. Abe,D. Wolverton, E. P. Crane, K. A. Ward,M. Nelson, B. L. Niell,K. Oh,K. R. Brandt, D. H. Bang,H. Ojeda-Fournier,M. Eghtedari, P. A. Sheth,W. K. Bernreuter,H. Umphrey, M. A. Rosen,B. Dogan, W. Yang,B. Joe,L. van't Veer,G. Hirst, R. Lancaster, A. Wallace, M. Alvaredo,F. Symmans,S. Asare,J. C. Boughey

CANCER RESEARCH（2019）

Cited0Views0Bibtex

Abstract P3-10-02: Identifying Breast Cancer Molecular Phenotypes to Predict Response in a Modern Treatment Landscape: Lessons from ˜1000 Patients Across 10 Arms of the I-SPY 2 TRIAL

DM Wolf,C Yau,J Wulfkuhle,E Petricoin, M Campbell,L Brown-Swigart,G Hirst,S Asare, Z Zhu, EP Lee, A Delson,P Pohlmann,N Hylton,MC Liu,F Symmans,A DeMichele,D Yee,D Berry,L Esserman,L van 't Veer

Cancer researchno. 4_Supplement (2019): P3-02

Cited0Views0Bibtex

The use of 18F-FDG PET/CT as an initial staging procedure for stage II-III breast cancer reduces false positives, costs, and time to treatment: A multicenter value analysis in the I-SPY2 trial

C. J. Hyland,F. Varghese,C. Yau,H. Beckwith,K. Khoury,W. Varnado,G. Hirst,J. Chien,D. Yee,C. Isaacs,A. Forero-Torres,L. Esserman,M. Melisko

CANCER RESEARCH（2019）

Cited0Views0Bibtex

Identifying breast cancer molecular phenotypes to predict response in a modern treatment landscape: Lessons from (similar to)1000 patients across 10 arms of the I-SPY 2 TRIAL

D. M. Wolf,C. Yau,J. Wulfkuhle,E. Petricoin, M. Campbell,L. Brown-Swigart,G. Hirst,S. Asare, Z. Zhu, E. P. Lee, A. Delson,P. Pohlmann,N. Hylton,M. C. Liu,F. Symmans,A. DeMichele,D. Yee,D. Berry,L. Esserman,L. van 't Veer

CANCER RESEARCH（2019）

Cited0Views0Bibtex

Abstract P3-10-06: Expression-based Immune Signatures As Predictors of Neoadjuvant Targeted-/Chemo-therapy Response: Experience from the I-SPY 2 TRIAL of ˜1000 Patients Across 10 Therapies

C. Yau,D. M. Wolf,M. Campbell,P. Savas, S. Lin,L. Brown-Swigart,G. Hirst,S. Asare, Z. Zhu,S. Loi,A. DeMichele,D. Yee,D. Berry,L. Esserman,L. van 't Veer

Cancer research（2019）

Cited8Views0Bibtex

BluePrint basal subtype predicts neoadjuvant therapy response in similar to 400 HR+HER2-patients across 8 arms in the I-SPY 2 TRIAL

L. J. van't Veer,D. Wolf,C. Yau, Z. Zhu,A. Glas,W. Audeh,L. Brown Swigart,S. Asare,G. Hirst,A. Demichele,D. Yee,L. Esserman

EUROPEAN JOURNAL OF CANCER（2018）

Cited2Views0Bibtex

Abstract PD6-08: Analysis of Immune Infiltrates (assessed Via Multiplex Fluorescence Immunohistochemistry) and Immune Gene Expression Signatures As Predictors of Response to the Checkpoint Inhibitor Pembrolizumab in the Neoadjuvant I-SPY 2 Trial

M Campbell,C Yau,A Borowsky,S Vandenberg,D Wolf,D Rimm,R Nanda,M Liu,L Brown-Swigart,G Hirst,S Asare,L van't Veer,D Yee,A DeMichele,D Berry,L Esserman

Cancer research（2018）

Cited5Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn